Effects of a structured educational intervention in moderate-to-severe elderly asthmatic subjects

Autor: Nicola Scichilone, Gabriella Guarnieri, Amelia Grosso, Ilaria Baiardini, Pietro Pirina, Antonio Molino, Federica Albicini, Vincenzo Patella, Fulvio Braido, Rita Raccanelli, Andrea Vianello, F. Di Marco, G. Steinhilber, Carolina Lombardi, Mariangiola Crivellaro, Erminia Ridolo, Alida Benfante, Erica Gini, Manlio Milanese, R. De Tullio, Mario Polverino, Maria Teresa Costantino, Angelo Corsico, Giovanni Rolla, Marcello Cottini, Silvia Terraneo, Marco Caminati
Přispěvatelé: Milanese, M., Terraneo, S., Baiardini, I., Di Marco, F., Corsico, A., Molino, A., Scichilone, N., Albicini, F., Benfante, A., Braido, F., Caminati, M., Costantino, M. T., Cottini, M., Crivellaro, M., De Tullio, R., Gini, E., Grosso, A., Guarnieri, G., Lombardi, C., Patella, V., Pirina, P., Polverino, M., Raccanelli, R., Ridolo, E., Rolla, G., Steinhilber, G., Vianello, A., Milanese M., Terraneo S., Baiardini I., Di Marco F., Corsico A., Molino A., Scichilone N., Albicini F., Benfante A., Braido F., Caminati M., Costantino M.T., Cottini M., Crivellaro M., De Tullio R., Gini E., Grosso A., Guarnieri G., Lombardi C., Patella V., Pirina P., Polverino M., Raccanelli R., Ridolo E., Rolla G., Steinhilber G., Vianello A.
Rok vydání: 2019
Předmět:
Vital capacity
ACT
asthma control test

Exacerbation
SAE
severe asthma exacerbation

SF12
chlorofluorocarbons
mental health composite score
EDUCA
elderly and device use in chronic asthma

PCS
physical health composite score

AHDS
hospital anxiety depression scale

Asthma
CFC
chlorofluorocarbons

Device misuse
Education
Elderly
FEV1
forced expiratory volume 1s second

FVC
forced vital capacity

ICS
inhaled corticosteroids

LABA
long-acting β2 agonist

LAMA
long-acting muscarinic antagonists

MCS
mental health composite score

PROs
patient-reported outcomes

SF12
short form health survey

mMRC
modified medical research council

EDUCA
FEV1
0302 clinical medicine
Immunology and Allergy
Medicine
030223 otorhinolaryngology
biology
severe asthma exacerbation
modified medical research council
LAMA
SAE
Lama
elderly and device use in chronic asthma
Metered-dose inhaler
Dry-powder inhaler
CFC
PCS
patient-reported outcomes
mMRC
lcsh:Immunologic diseases. Allergy
Pulmonary and Respiratory Medicine
long-acting β2 agonist
medicine.medical_specialty
Immunology
LABA
physical health composite score
Article
AHDS
03 medical and health sciences
FEV1/FVC ratio
long-acting muscarinic antagonists
forced vital capacity
Internal medicine
forced expiratory volume 1s second
business.industry
Inhaler
asthma control test
biology.organism_classification
medicine.disease
ACT
FVC
MCS
hospital anxiety depression scale
030228 respiratory system
ICS
PROs
short form health survey
inhaled corticosteroids
lcsh:RC581-607
business
Zdroj: The World Allergy Organization Journal
World Allergy Organization Journal, Vol 12, Iss 6, Pp-(2019)
ISSN: 1939-4551
Popis: Background: Adherence to inhaled drugs is linked to patients’ satisfaction with their device, and an incorrect use can negatively affect the outcomes of asthma treatment. We speculated that this is particularly true in elderly asthmatic subjects. Aim: We performed a national pre-post interventional multicentre study, enrolling moderate-to-severe asthmatic subjects aged ≥65 ​years treated with fixed inhaled combination drugs by dry powder inhaler (DPI) or pressurized metered dose inhaler (pMDI). Adherence and critical errors were evaluated by means of validated questionnaires at first visit (V1) and after 3–6 months (V2). At V1, subjects underwent intensive training on the correct use of their device by physical demonstration. Results: A total of 411 asthmatics (F/M: 238/173, mean age±SD: 72 ​± ​5 ​years) participated to the study. At V1, 50% of the study subjects showed an Asthma Control Test (ACT) score ≤19 despite GINA step 3 and 4 treatment, and 40% had experienced at least one severe asthma exacerbation in the previous year. Poor adherence to treatment was recorded in 43% of subjects, and at least one error in using the device was registered in 56% of subjects. At V2, available for 318 patients, both the percentage of individuals with poor adherence and with at least one critical error significantly decreased (from 46% to 25%, and from 49% to 25%, respectively; p ​
Databáze: OpenAIRE